Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Promega Corp | 102 |
| 2 | Xerox Corp | 56 |
| 3 | New York Blood Center | 20 |
| 4 | University of Massachusetts Chan Medical School | 17 |
| 5 | Kreatech Biotechnology BV | 12 |
| 6 | Boston University | 11 |
| 7 | Yissum Research Development Co of Hebrew University of Jerusalem | 8 |
| 8 | Bausch Health Ireland Ltd | 7 |
| 9 | Boston Children's Hospital | 7 |
| 10 | Eastman Kodak Co | 7 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | G01N | Investigating / analysing materials | 221 |
| 2 | C12N | Microorganisms, enzymes | 140 |
| 3 | C07K | Peptides | 136 |
| 4 | A61K | Medicinal preparations | 123 |
| 5 | C12Q | Measuring/testing involving enzymes | 109 |
| 6 | A61P | Therapeutic activity (drug indications) | 87 |
| 7 | Y10S | Cross-reference (legacy) | 77 |
| 8 | C12Y | Enzyme nomenclature (EC numbers) | 70 |
| 9 | C07D | Heterocyclic compounds | 64 |
| 10 | C07F | Organometallic compounds | 45 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Lipid Membrane Structure and Behavior | 1 |
| 2 | Monoclonal and Polyclonal Antibodies Research | 1 |
| 3 | Ultrasound and Hyperthermia Applications | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | George M. Hahn | Stanford University | 8 |
| 2 | Glenn C. Rice | Stanford University | 7 |
| 3 | George A. Fisher | Stanford University | 4 |
| 4 | John P. Lovejoy | California Institute for Medical Research | 4 |
| 5 | Yoji Arata | Water Research Institute | 4 |
| 6 | Gillian M. K. Humphries | California Institute for Medical Research | 3 |
| 7 | Ichio Shimada | The University of Tokyo | 3 |
| 8 | Koichi Kato | Nagoya City University | 3 |
| 9 | Robin L. Anderson | Stanford University | 3 |
| 10 | Shiao Y. Woo | Stanford University | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Cellular Membrane Composition Defines Aβ-Lipid Interactions | 2001 | 97 | Alzheimer's disease research and treatments |
| Two-Dimensional Molecular Imprinting Approach to Produce Optical Biosensor Recognition Elements | 2006 | 52 | Advanced biosensing and bioanalysis techniques |
| Cholesterol-free phospholipid domains may be the membrane feature selected by Nε-dansyl-L-lysine and merocyanine 540 | 1983 | 48 | Lipid Membrane Structure and Behavior |
| Continuous electrophoretic separations in narrow channels coupled to small-bore capillaries | 1993 | 46 | Microfluidic and Capillary Electrophoresis Applications |
| Dynamical structure of the antibody combining site as studied by proton-nitrogen-15 shift correlation NMR spectroscopy | 1992 | 34 | Glycosylation and Glycoproteins Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Dns-lysine?
Which organization holds the most patents involving Dns-lysine?
What are the main research topics associated with Dns-lysine in the scientific literature?
What technical patent areas are most prevalent for Dns-lysine applications?
How has patent activity for Dns-lysine changed in recent years?